Report Highlights
The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Report Includes
- An overview of the global markets for cardiovascular devices
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of key cardiovascular procedures, disease areas, and end users
- Information on cardiovascular devices, including diagnostics and monitoring, interventional cardiology, cardiac rhythm management, cardiac assist, and other vascular surgery devices
- Analysis of market drivers, restraints, and opportunities
- Coverage of key mergers and acquisitions, new product launches, agreements, collaborations, and partnerships
- Patent analysis of various devices by year and by assignee
- Profiles of major players in the industry including Abbott Vascular, Abiomed Inc., B. Braun Melsungen AG, Cardinal Health Inc., GE Healthcare, Johnson & Johnson, Medtronic PLC and Philips Healthcare
Report Scope
Cardiovascular devices are used to diagnose and treat various heart diseases and related health problems. With the medical needs of patients at an all-time high, any increase in incidences will only lead to a significant growth of cardiovascular market. This report analyzes the market trends of cardiovascular devices, future growth and regional market of the same.
This report covers cardiovascular diseases such as arrhythmia, cardiomyopathy, coronary heart disease, myocardial infarction, congestive heart failure, congenital heart disease, hypertension, heart infections, and valvular diseases. The procedures considered in this report are cardiac resynchronization therapy, heart transplantation, coronary artery bypass surgery, valve replacement, beating heart surgery, transmyocardial revascularization surgery, balloon valvuloplasty, and renal denervation surgery. The end-users covered in this report include home and ambulatory care, hospitals, diagnostic laboratories, and research laboratories. The market has been segmented based on device type and geography. The equipment/products/systems include but are not limited to the segments considered in this report. By type, the market in this report is segmented into diagnostics and monitoring devices, and cardiovascular surgical devices. The diagnostic and monitoring cardiac devices include ECG and echocardiogram devices. The cardiovascular surgical devices considered in this report are interventional cardiology devices like stents, angioplasty balloons, catheters and accessories, guidewires, cannulae, and valves; cardiac rhythm management devices like implantable cardiac defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, pacemakers and leads; cardiac assist devices (CAD) like ventricular assist devices, intra-aortic balloon pump, total artificial heart; and other vascular surgery devices like endovascular grafts, IVC filters and occlusion devices.
The research uncovers many paradigms shifts in the studied market, in terms of regional competitive advantage, competitive landscape among the key players in the cardiovascular devices industry, and market dynamics. A holistic study of the market has been carried out by incorporating various factors right from country-specific demographic conditions and business cycles to market specific microeconomic influences that were needed to analyze the future trends of this market. The report provides a comprehensive review of market drivers, restraints, opportunities, and available patents. Key vendor analysis, new products and developments with financials are also provided to enable easy decision making.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Commercial Amino Acids (BIO007N)
- Technical Textiles: Global Markets (CHM136C)
- Brain-Computer Interface: Global Markets (IAS180B)
- CRISPR Technology: Global Markets (HLC258C)
- Global IoT Testing Services Market (IFT307A)
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Defibrillator: Global Market Outlook
This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and rising opportunities in the developed and developing world.
Cardiac Biomarkers: Technologies and Global Markets
The global market for cardiac biomarkers is estimated to increase from $13.4 billion in 2022 to reach $23.8 billion by 2027, at a compound annual growth rate (CAGR) of 12.2% from 2022 through 2027.
Global Markets for Catheters
The global market for catheters is estimated to increase from $30.8 billion in 2022 to reach $42.5 billion by 2027, at a compound annual growth rate (CAGR) of 6.6% from 2022 through 2027.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More